Alawneh et al. found that the factors associated with a shorter survival time were type of malignancy, bilateral hydronephrosis, serum albumin <3.5 mg/dL, presence of metastases, ascites, or pleural effusion. The gene discussed is ALB; the disease is Pleural effusion.